Nrgene (NRGN) Stock Statistics & Valuation Metrics

Nrgene has a market cap or net worth of ₪33.94M. The enterprise value is 7.00M.

Nrgene has 13,313,626 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nrgene’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -34.06%.

The current PE Ratio of Nrgene is ―. Nrgene’s PEG ratio is 0.00.

In the last 12 months, Nrgene had revenue of 3.17M and earned -1.50M in profits. Earnings per share was -0.13.

In the last 12 months, operating cash flow was 855.00K and capital expenditures -783.00K, giving a free cash flow of 72.00K billion.

Nrgene pays an annual dividend of ―, resulting in a dividend yield of ―

Nrgene upcoming earnings date is Mar 31, 2026, TBA (Not Confirmed).

Nrgene as a current ratio of 1.23, with Debt / Equity ratio of 4.20%

In the past 12 months, Nrgene has paid 35.00K in taxes.

Nrgene EV to EBITDA ratio is 4.10, with an EV/FCF ratio of -54.97.

Nrgene has ₪5.30M in cash and marketable securities with ₪181.00K in debt, giving a net cash position of ₪5.12M billion.

Gross margin is 60.57%, with operating margin of -49.53%, and net profit margin of -47.38%.

The average price target for Nrgene is ―, which is 11.43% higher than the current price. The consensus rating is ―